Table 2.
BCFH+ |
BCFH- |
||||||
---|---|---|---|---|---|---|---|
% Methylation |
% Methylation |
||||||
Amplicon | No. | Median | IQR | No. | Median | IQR | P value |
ADRB1 | 171 | 23.0 | 8.9 | 142 | 24.9 | 10.4 | 0.125 |
ARHGEF7 | 160 | 36.6 | 12.6 | 124 | 37.1 | 17.2 | 0.728 |
BRCA1 | 198 | 83.5 | 12.7 | 160 | 83.3 | 13.9 | 0.648 |
CCDC85A | 198 | 36.6 | 11.0 | 157 | 35.9 | 11.9 | 0.463 |
CCNL1 | 166 | 0.1 | 0.2 | 131 | 0.1 | 0.4 | 0.799 |
CDH1 | 201 | 5.9 | 2.7 | 163 | 6.1 | 2.8 | 0.612 |
CELF4 | 198 | 54.3 | 15.5 | 150 | 51.9 | 13.5 | 0.06 |
Chr 11 | 169 | 9.4 | 11.8 | 125 | 9.0 | 10.4 | 0.881 |
Chr 12 | 201 | 78.0 | 6.1 | 156 | 77.5 | 8.2 | 0.265 |
Chr 16 | 209 | 81.9 | 11.9 | 165 | 81.7 | 13.2 | 0.597 |
Chr 4 | 161 | 86.0 | 14.4 | 139 | 85.7 | 14.6 | 0.673 |
CYP1A1 | 177 | 44.4 | 26.9 | 139 | 43.4 | 27.0 | 0.178 |
DLGAP2 | 199 | 97.2 | 1.6 | 163 | 97.2 | 1.4 | 0.498 |
ESR1 | 196 | 55.0 | 21.6 | 161 | 49.2 | 25.2 | 0.003 |
GAB2 | 168 | 98.7 | 3.7 | 136 | 99.0 | 3.2 | 0.398 |
GNA12 | 138 | 31.6 | 43.8 | 105 | 34.7 | 32.8 | 0.646 |
MCHR2 | 210 | 11.2 | 5.8 | 165 | 11.1 | 5.4 | 0.98 |
OBSCN | 182 | 94.2 | 3.7 | 148 | 94.1 | 3.6 | 0.696 |
PCDHGB1 | 215 | 38.0 | 11.0 | 171 | 38.8 | 11.5 | 0.447 |
PEX14 | 191 | 70.6 | 14.4 | 152 | 72.9 | 14.8 | 0.09 |
RAD23B | 134 | 97.7 | 2.3 | 119 | 98.1 | 2.5 | 0.407 |
RAD51L1 | 130 | 98.3 | 3.6 | 97 | 98.7 | 3.2 | 0.896 |
SEC16B | 153 | 75.1 | 18.9 | 119 | 72.8 | 16.8 | 0.026 |
SLC39A14 | 199 | 88.4 | 13.6 | 162 | 90.3 | 11.8 | 0.238 |
TCF7L2 | 169 | 42.7 | 29.6 | 143 | 45.4 | 27.9 | 0.671 |
TERT | 176 | 97.6 | 3.8 | 142 | 97.8 | 3.6 | 0.713 |
XRCC3 | 186 | 78.4 | 7.2 | 143 | 78.7 | 7.8 | 0.691 |
ZFPM2 | 192 | 64.5 | 26.1 | 152 | 65.6 | 20.0 | 0.088 |
ZNF483 | 201 | 36.3 | 6.5 | 157 | 37.4 | 7.3 | 0.384 |